CJC-1295 / Ipamorelin
Also known as: CJC-1295/Ipamorelin, CJC-1295 and Ipamorelin blend, GHRH/GHRP stack
CJC-1295 / Ipamorelin is a marketing name for a blend of two synthetic peptides used together as growth-hormone secretagogues. CJC-1295 is a long-acting analog of growth-hormone-releasing hormone (GHRH), and ipamorelin is a selective growth-hormone-releasing peptide (GHRP) that mimics ghrelin. Sold together, they are marketed to prompt the pituitary to release more of the body's own growth hormone. It is not a single drug or an FDA-approved product; its effects are the combined effects of its two components.
What's in this blend
CJC-1295 / Ipamorelin combines the following peptides. The blend's effects and risks are those of its components together; open each for its own evidence and safety.
How it works
CJC-1295 is designed to extend the action of GHRH, the signal that tells the pituitary gland to release growth hormone, while ipamorelin acts on a separate ghrelin/GHRP receptor to prompt a pulse of GH release with relatively little reported effect on cortisol or appetite. The pairing is intended to raise growth hormone and downstream IGF-1 through the body's own pathways rather than by injecting growth hormone directly. How the combination behaves over time in humans has not been established in controlled clinical trials.
Researched uses
- Marketed for recovery, sleep quality, and body composition by raising the body's own growth hormone
- The individual peptides have been studied for growth-hormone release in pharmacology research
- Used off the licensed pathway by some adults for anti-aging and performance goals, though both peptides are banned in sport
Neither component is FDA-approved, and there is no FDA-approved CJC-1295/Ipamorelin product. Neither is on the FDA's list of bulk substances permitted for pharmacy compounding, both are sold as research chemicals, and CJC-1295 is among the peptides the FDA has flagged over safety concerns. Providers listed here dispense with a prescription and describe a licensed pharmacy, but because these peptides sit outside the settled compounding rules the legal pathway is not clear-cut, so review each provider's own sourcing. Both peptides appear on the World Anti-Doping Agency (WADA) Prohibited List.
CJC-1295 / Ipamorelin providers compared
Providers that have passed our rubric review are listed first, then ordered by the total cost of a 3-month protocol. We average every cost to a standard 3-month protocol, which our medical advisors consider the best basis for comparing cost and value, and the headline figure folds in any one-time consult or provider-review fee plus three months of membership. Use the calculator below to adjust the length and see the same total broken out.
| Provider | Sourcing | What's included | Verified | Visit provider | |
|---|---|---|---|---|---|
RxPepsDirectVerified CJC-1295/Ipamorelin | 503A pharmacy | $339 for 3 months (est.) ≈3 vials · $100/vial incl. $39 consult | Consult fee extra · no membership | Jul 8, 2026 vial price | View |
Live VitalVerified CJC-1295/Ipamorelin Free live doctor consult | 503A pharmacy | $349 for 3 months | No consult fee · no membership · shipping included | Jul 6, 2026 | View |
We average every cost to a standard 3-month protocol, which our medical advisors consider the best window for comparing cost and value. Monthly plans are multiplied by 3 and 3-month programs are taken as billed; each provider's own sticker price and cadence are shown underneath.
The headline figure is the total 3-month cost: the medication plus any one-time consult or provider-review fee (for example RxPepsDirect's $39) and three months of any membership fee. Where a fee is not published we fold in what is known and flag that other fees may apply.
Per-vial providers are averaged to a 3-month protocol at roughly one vial per month (3 vials), marked "est.", with the per-vial price shown underneath. Actual vial count depends on your dose and protocol.
Prices are gathered from each provider's public pages. The "Verified" date is when we last checked the provider's sticker price; for per-vial providers it is the vial price that was verified, not the averaged 3-month total.
Value check: total cost of therapy
This is the real value comparison. A sticker price hides consult and membership fees, so this adds everything up for a full protocol of CJC-1295 / Ipamorelin and ranks by true total cost. We default to a 3-month protocol, the window our medical advisors consider best for judging value.
Per-vial providers are estimated at about one vial per month (3 vials for 3 months), plus any one-time consult. Actual vial count depends on your dose and protocol, so the real cost may run higher or lower.
Safety notes
The safety of the CJC-1295 / Ipamorelin blend has not been established in humans. Growth-hormone secretagogues can raise IGF-1 and may cause water retention, joint aches, numbness, or effects on blood sugar, and the long-term consequences of chronically raising growth hormone are not well characterized. Combining two investigational peptides compounds that uncertainty, and composition varies by provider. Anything sold outside the licensed pharmacy system is not verified for identity, purity, or sterility.
In the news
- Inside the booming, gray-market world of injectable peptides The Hill
Reporting on the gray market for research-use-only injectable peptides sold outside the licensed pharmacy system, and the associated health concerns.
CJC-1295 / Ipamorelin questions
How much does CJC-1295 / Ipamorelin cost?
Across the licensed providers tracked here, a full 3-month protocol of CJC-1295 / Ipamorelin totals $339 to $349, depending on the provider, dose, and what is included. We average every cost to a standard 3-month protocol, which our medical advisors consider the best basis for comparing cost and value, and the total folds in any one-time consult or provider-review fee and three months of membership. Each price shows the date the provider's sticker price was verified.
What is CJC-1295 / Ipamorelin?
It is a blend of two growth-hormone peptides, CJC-1295 (a GHRH analog) and ipamorelin (a GHRP), used together to prompt the body's own growth-hormone release. Doses and ratios vary by provider.
Is it FDA-approved?
No. Neither component is FDA-approved, and there is no approved combination product. The blend is investigational and its combined effects are unproven in humans.
Is it allowed in sport?
No. Both CJC-1295 and ipamorelin are on the WADA Prohibited List, so the blend is banned in competitive sport.
Related reading
- Peptide Therapy vs TRT: An Honest ComparisonAn independent, evidence-honest look at how TRT and peptide therapy differ on FDA status, research, fertility, safety, and finding legal, prescription-based care.
- Peptides Studied for Energy and PerformanceAn independent look at CJC-1295, ipamorelin, and MOTS-c for energy and performance: what the research shows, safety and legality, and how to find licensed care.